We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
Cap. Flow
+$3.01B
Cap. Flow %
28.27%
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$96.9M
2
MRK icon
Merck
MRK
+$73.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.1M
4
ILMN icon
Illumina
ILMN
+$40.4M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$57.2M
2
IMMU
Immunomedics Inc
IMMU
+$51.7M
3
KMB icon
Kimberly-Clark
KMB
+$28.5M
4
BPMC
Blueprint Medicines
BPMC
+$26.5M
5
ANET icon
Arista Networks
ANET
+$22.7M

Sector Composition

Rank Sector Weight
1 Healthcare 35.77%
2 Technology 20.35%
3 Consumer Discretionary 9.49%
4 Communication Services 7.69%
5 Financials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHG icon
726
Shinhan Financial Group
SHG
$32.1B
$240K ﹤0.01%
10,460
+812
+8% +$20.4K
ARKK icon
727
ARK Innovation ETF
ARKK
$5.59B
$239K ﹤0.01%
+2,600
New +$223K
DRE
728
DELISTED
Duke Realty Corp.
DRE
$235K ﹤0.01%
6,362
-1,155
-15% -$43.5K
INGR icon
729
Ingredion
INGR
$6.42B
$232K ﹤0.01%
3,073
-332
-10% -$27K
CHGG icon
730
Chegg
CHGG
$116M
$221K ﹤0.01%
+3,100
New +$228K
WEC icon
731
WEC Energy
WEC
$36.3B
$212K ﹤0.01%
+2,189
New +$204K
CIB icon
732
Grupo Cibest SA
CIB
$21.2B
$210K ﹤0.01%
8,210
-483,168
-98% -$13.2M
RTX icon
733
RTX Corp
RTX
$290B
$201K ﹤0.01%
3,500
-300
-8% -$18.3K
CCJ icon
734
Cameco
CCJ
$36.8B
$197K ﹤0.01%
19,546
– –
AKBA icon
735
Akebia Therapeutics
AKBA
$338M
$176K ﹤0.01%
70,000
-1,159,346
-94% -$10.2M
PBR icon
736
Petrobras
PBR
$120B
$172K ﹤0.01%
24,100
-7,130
-23% -$60.6K
ARAY icon
737
Accuray
ARAY
$27.5M
$168K ﹤0.01%
70,000
– –
AAL icon
738
American Airlines Group
AAL
$9.82B
$160K ﹤0.01%
13,000
– –
CIG icon
739
CEMIG Preferred Shares
CIG
$6.06B
$151K ﹤0.01%
153,981
+15,511
+11% +$17.1K
M icon
740
Macy's
M
$6.51B
$142K ﹤0.01%
25,000
– –
VALE icon
741
Vale
VALE
$62.3B
$129K ﹤0.01%
12,210
+1,500
+14% +$16.8K
ASUR icon
742
Asure Software
ASUR
$242M
$121K ﹤0.01%
16,000
– –
KIM icon
743
Kimco Realty
KIM
$17.5B
$113K ﹤0.01%
10,029
-5,000
-33% -$59K
ASX icon
744
ASE Group
ASX
$68.3B
$110K ﹤0.01%
26,950
+8,794
+48% +$39.2K
CHMA
745
DELISTED
Chiasma, Inc. Common Stock
CHMA
$101K ﹤0.01%
23,500
– –
GT icon
746
Goodyear
GT
$2.09B
$100K ﹤0.01%
13,031
– –
FBIO icon
747
Fortress Biotech
FBIO
$111M
$91K ﹤0.01%
1,500
– –
SIRI icon
748
SiriusXM
SIRI
$11B
$84K ﹤0.01%
1,575
– –
SKT icon
749
Tanger
SKT
$4.78B
$84K ﹤0.01%
14,000
– –
QCLS
750
Q/C Technologies Inc
QCLS
$19.7M
$81K ﹤0.01%
6
– –
28 29
30
31 32

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2020 Portfolio in Review

As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.

  • Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
  • Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
  • Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
  • Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
  • Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
  • Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
  • Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.

Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.